INS and diabetes mellitus: Diabetes patients have insulin signal transduction pathway changes or defects, which are associated with lower levels of the molecules of insulin signaling such as “Insulin receptor substrate-1 (IRS-1) and phosphatidylinositol 3-kinase PI3K” (Dhanya et al., 2017).